Circulating tumour DNA in patients with melanoma receiving targeted therapy

被引：0
|
作者：
Forschner, Andrea [1 ]
机构：
[1] Univ Hosp Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 03期
关键词：
BRAF;
D O I：
10.1016/S1470-2045(20)30758-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：291 / 293
页数：3
相关论文
共 50 条
  • [31] Methylation of circulating DNA in melanoma patients.
    Hengge, U. R.
    Marini, A.
    Mirmohammadsadegh, A.
    Nambiar, S.
    Gustrau, A.
    Ruzicka, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 459S - 459S
  • [32] Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
    Tsao, Simon Chang-Hao
    Weiss, Jonathan
    Hudson, Christopher
    Christophi, Christopher
    Cebon, Jonathan
    Behren, Andreas
    Dobrovic, Alexander
    SCIENTIFIC REPORTS, 2015, 5
  • [33] Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
    Simon Chang-Hao Tsao
    Jonathan Weiss
    Christopher Hudson
    Christopher Christophi
    Jonathan Cebon
    Andreas Behren
    Alexander Dobrovic
    Scientific Reports, 5
  • [34] Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients
    Ashida, Atsuko
    Sakaizawa, Kaori
    Uhara, Hisashi
    Okuyama, Ryuhei
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (10) : 1212 - 1218
  • [35] Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy
    Shinozaki, Masaru
    O'Day, Steven J.
    Kitago, Minoru
    Amersi, Farin
    Kuo, Christine
    Kim, Joseph
    Wang, He-Jing
    Hoon, Dave S. B.
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2068 - 2074
  • [36] Melanoma and Sarcoidosis in Patients Receiving or Not Antineoplastic Therapy
    Gouveris, Panagiotis
    Zouki, Dionysia N.
    Sarris, Evangelos G.
    Kolilekas, Likourgos
    Tryfonopoulos, Dimitrios
    Papaxoinis, George
    Demiri, Stamatina
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 1059 - 1065
  • [37] Longitudinal Circulating Tumor-DNA Profiling Predicts Therapy Response in Melanoma Patients
    Calgua, Byron
    Keller, Eveline
    Jermann, Philip
    Tolnay, Markus
    Levesque, Mitchell
    Alborelli, Ilaria
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S35 - S36
  • [38] Circulating tumour DNA and oncometabolites in patients with intrahepatic cholangiocarcinoma
    Winter, H.
    Kaisaki, P.
    Harvey, J.
    Carter, R.
    Sharma, R. A.
    Tayor, J. C.
    Mccullagh, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Detection of circulating tumour DNA in the blood of cancer patients
    Hainaut, P
    M S-MEDECINE SCIENCES, 2000, 16 (03): : 446 - 446
  • [40] Circulating tumour DNA sequencing: From targeted mutations to whole genome resolution
    Lo, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S69 - S69
12345